0169-2081Level 3
Alhemo (concizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** CONCIZUMAB
**Strength:** 100 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Novo Nordisk
**Marketing category:** BLA (BLA761315)
**Pharmacologic class:** Tissue Factor Pathway Inhibitor Antagonist [EPC], Tissue Factor Pathway Inhibitor Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0169-2081Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.